Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 80 | 101 | +21 |
| Shares | 34.9M | 34.0M | −840.1K (−2.4%) |
| Value | $512.1M | $181.7M | −$330.5M (−64.5%) |
New holders (33)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (12)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jennison Associates LLC | 985,072 | $14.5M |
| Rafferty Asset Management, LLC | 68,423 | $1.01M |
| UBS Group AG | 62,399 | $917.0K |
| Laurion Capital Management LP | 47,821 | $703.0K |
| Prudential Financial Inc | 35,230 | $564.0K |
| M&T Bank Corp | 20,536 | $302.0K |
| SG Americas Securities, LLC | 13,650 | $201.0K |
| ProShare Advisors LLC | 12,447 | $184.0K |
| MetLife Investment Management | 11,317 | $166.4K |
| Metropolitan Life Insurance Co | 8,707 | $128.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,620 | $24.0K |
| Parallel Advisors, LLC | 628 | $9.00K |